1Detry O,Arkadopoutos N,Ting P.et al . Clinical use of a bioartificiat liver in the treatment of acetaminophen-induced fulminant hepatic faiture[J]. Am Surg, 1999,65(10):934-938.
2Chen SC, Multon C.Kahaku E, et al . Treatment of severe liver failure with a bioartificiat liver[J]. Ann N Y Aead Sci, 1997, 831 350-360.
3Ellis,AJ. Hughes RD, Nicholl D. et al . Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the Bio-Logic-DT[J].Int J Argans,1999,22(1):27-34.
4Watanabe FD, Mullon CJ. Hewitt WR, et al . Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial[J]. Ann Surg.1997. 225(5): 484-494.
5Te Velde AA.Flendrig LM, I.adiges. NC. et al. Immunological consequences of the use of xenogeneic hepatocytes in a bioartificia liver for acute liver failure[J]. Int J Artif Organs, 1997,20(1,) 229-233.
6Baquerizo A. Mhoyan A.Kearns Jonker M.et al. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an exvivo model of pig to human xenotransplantation[J]. Transplantation.1999 67(1): 5-18.
7Rozga J, Demetriou AA, Artificial liver: Evolution and future perspectives[J]. ASAIO J. 1995,41(4):831-837.
8Jauregui HO. Cellular component of bioartificial liver support systems[J]. Artif Organs,1999,23(10):889-893.
